Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
{{output}}
Introduction: Anticoagulation without bleeding is an ideal goal in treating thrombosis, however, this goal has not been achieved. All current anticoagulants are associated with significant bleeding which limits their safe use. Genetic and pharmacological findi... ...